The Impact of Accelerometer Use in Exercise-Associated Hypoglycemia Prevention in Type 1 Diabetes

Background: Exercise-associated hypoglycemia is a common adverse event in people with type 1 diabetes. Previous in silico testing by our group demonstrated superior exercise-associated hypoglycemia mitigation when a predictive low glucose suspend (PLGS) algorithm was augmented to incorporate activity data. The current study investigates the effectiveness of an accelerometer-augmented PLGS algorithm in an outpatient exercise protocol. Methods: Subjects with type 1 diabetes on insulin pump therapy participated in two structured soccer sessions, one utilizing the algorithm and the other using the subject’s regular basal insulin rate. Each subject wore their own insulin pump and a Dexcom G4™ Platinum continuous glucose monitor (CGM); subjects on-algorithm also wore a Zephyr BioHarness™ 3 accelerometer. The algorithm utilized a Kalman filter with a 30-minute prediction horizon. Activity and CGM readings were manually entered into a spreadsheet and at five-minute intervals, the algorithm indicated whether the basal insulin infusion should be on or suspended; any changes were then implemented by study staff. The rate of hypoglycemia during and after exercise (until the following morning) was compared between groups. Results: Eighteen subjects (mean age 13.4 ± 3.7 years) participated in two separate sessions 7-22 days apart. The difference in meter blood glucose levels between groups at each rest period did not achieve statistical significance at any time point. Hypoglycemia during the session was recorded in three on-algorithm subjects, compared to six off-algorithm subjects. In the postexercise monitoring period, hypoglycemia occurred in two subjects who were on-algorithm during the session and four subjects who were off-algorithm. Conclusions: The accelerometer-augmented algorithm failed to prevent exercise-associated hypoglycemia compared to subjects on their usual basal rates. A larger sample size may have achieved statistical significance. Further research involving an automated system, a larger sample size, and an algorithm design that favors longer periods of pump suspension is necessary.

[1]  N. Herbold,et al.  Endurance Athletes and Type 1 Diabetes , 2011, The Diabetes educator.

[2]  Darrell M. Wilson,et al.  Inpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm , 2012, Journal of diabetes science and technology.

[3]  Bruce A Buckingham,et al.  The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. , 2006, Diabetes care.

[4]  H Peter Chase,et al.  Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. , 2004, Pediatrics.

[5]  E. Shahar,et al.  High Incidence of Hypoglycemic Episodes with Neurologic Manifestations in Children with Insulin Dependent Diabetes Mellitus , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[6]  G. Chiari,et al.  Adherence to physical activity in young people with type 1 diabetes. , 2004, Acta bio-medica : Atenei Parmensis.

[7]  Eyal Dassau,et al.  Annals of the New York Academy of Sciences the Artificial Pancreas: Current Status and Future Prospects in the Management of Diabetes , 2022 .

[8]  B Wayne Bequette,et al.  The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes , 2014, Journal of diabetes science and technology.

[9]  D. BretonMarc,et al.  Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. , 2014 .

[10]  Marc D Breton,et al.  Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. , 2014, Diabetes technology & therapeutics.

[11]  David C Klonoff,et al.  Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. , 2012, Diabetes technology & therapeutics.

[12]  S. Donath,et al.  Poor adherence to integral daily tasks limits the efficacy of CSII in youth , 2011, Pediatric diabetes.